Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Innovate | VATE | Oct 31, 2024 | 5.87 | -3.77 |
Innovation Beverage Group | IBG | Oct 31, 2024 | 0.64 | 0.00 |
Innovative Eyewear | LUCY | Oct 31, 2024 | 8.20 | +4.86 |
Innovative Industrial Properties | IIPR | Oct 31, 2024 | 129.19 | -2.03 |
Innovative Industrial Properties A Pref | IIPR-A | Oct 31, 2024 | 26.27 | 0.00 |
Innovative Solutions and Support | ISSC | Oct 31, 2024 | 7.30 | +1.81 |
Innovex International | INVX | Oct 31, 2024 | 14.19 | 0.00 |
Innovid | CTV | Oct 31, 2024 | 1.91 | -2.05 |
Innoviva | INVA | Oct 31, 2024 | 19.56 | -0.76 |
Innoviz Technologies | INVZ | Oct 31, 2024 | 0.60 | -4.84 |
InnSuites Hospitality | IHT | Oct 31, 2024 | 1.91 | 0.00 |
Innventure | INV | Oct 31, 2024 | 10.17 | 0.00 |
Inogen | INGN | Oct 31, 2024 | 8.73 | -5.83 |
Inotiv | NOTV | Oct 31, 2024 | 1.77 | -2.75 |
Inovio Pharmaceuticals | INO | Oct 31, 2024 | 5.28 | -5.04 |
Inozyme Pharma | INZY | Oct 31, 2024 | 4.29 | -5.51 |
Inpixon | XTIA | Oct 31, 2024 | 0.06 | -3.51 |
InPoint Commercial Real Estate Pref A | ICR-A | Oct 31, 2024 | 21.85 | +5.71 |
Inseego | INSG | Oct 31, 2024 | 16.84 | -4.59 |
Insight Enterprises | NSIT | Oct 31, 2024 | 174.92 | -14.21 |
Insight Select Income Fund | INSI | Oct 31, 2024 | 17.30 | +0.57 |
Insmed | INSM | Oct 31, 2024 | 67.28 | -4.29 |
Insperity | NSP | Oct 31, 2024 | 78.77 | -2.89 |
Inspira Technologies Oxy B.H.N. | IINN | Oct 31, 2024 | 1.25 | -6.02 |
Inspirato A | ISPO | Oct 31, 2024 | 3.60 | -5.01 |
Inspire Medical Systems | INSP | Oct 31, 2024 | 195.04 | -0.77 |
Inspire Tactical Balanced ESG ETF | RISN | Oct 31, 2024 | 26.78 | -0.80 |
Inspire Veterinary Partners | IVP | Oct 31, 2024 | 0.28 | -0.64 |
Inspired Entertainment | INSE | Oct 31, 2024 | 9.54 | +0.42 |
InspireMD | NSPR | Oct 31, 2024 | 2.48 | -0.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.